Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (1-10 of 784) with videos related to

Pageof 79
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2009
Statin effects in CKD: is there a "point of no return"?Christoph Wanner
Clinical Kidney Journal|February 24, 2023
From WEDA to EDTA to ERA: 60 years of supporting European nephrology and countingChristoph Wanner
Circulation|July 23, 2019
Sodium Glucose Cotransporter 2 Inhibition and the Visualization of Kidney HemodynamicsChristoph Wanner
Seminars in Nephrology|January 6, 2009
Prevention of cardiovascular disease in chronic kidney disease patientsChristoph Wanner
The American Journal of Cardiology|June 14, 2017
EMPA-REG OUTCOME: The Nephrologist's Point of ViewChristoph Wanner
MMW Fortschritte Der Medizin|December 29, 2012
[Conflicts in the threshold for renal failure: when must the patient receive dialysis? (interview by Dr. Jochen Aumiler)]Christoph Wanner
The American Journal of Medicine|May 21, 2017
EMPA-REG OUTCOME: The Nephrologist's Point of ViewChristoph Wanner
Nature Reviews. Nephrology|January 9, 2018
Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney diseaseChristoph Wanner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
C-reactive protein risk prediction: adding cardiac hypertrophy to the listChristoph Wanner
Journal of Nephrology|May 23, 2002
Lipids in end-stage renal diseaseChristoph Wanner
Pageof 79

Showing results (1-10 of 784) with videos related to

Sort By:
Pageof 79
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2009
Statin effects in CKD: is there a "point of no return"?Christoph Wanner
Clinical Kidney Journal|February 24, 2023
From WEDA to EDTA to ERA: 60 years of supporting European nephrology and countingChristoph Wanner
Circulation|July 23, 2019
Sodium Glucose Cotransporter 2 Inhibition and the Visualization of Kidney HemodynamicsChristoph Wanner
Seminars in Nephrology|January 6, 2009
Prevention of cardiovascular disease in chronic kidney disease patientsChristoph Wanner
The American Journal of Cardiology|June 14, 2017
EMPA-REG OUTCOME: The Nephrologist's Point of ViewChristoph Wanner
MMW Fortschritte Der Medizin|December 29, 2012
[Conflicts in the threshold for renal failure: when must the patient receive dialysis? (interview by Dr. Jochen Aumiler)]Christoph Wanner
The American Journal of Medicine|May 21, 2017
EMPA-REG OUTCOME: The Nephrologist's Point of ViewChristoph Wanner
Nature Reviews. Nephrology|January 9, 2018
Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney diseaseChristoph Wanner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2002
C-reactive protein risk prediction: adding cardiac hypertrophy to the listChristoph Wanner
Journal of Nephrology|May 23, 2002
Lipids in end-stage renal diseaseChristoph Wanner
Pageof 79